Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment

Clinical trial NCT05717582 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05717582
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Castration-Sensitive Prostate Cancer

Start date: 2023-05-01
Primary completion: 2025-12-31
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.